Comparison of EGFR mutation between MPEs and matched MPTTs.

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu, Jiang-Yong
Yu, Si-Fan
Wang, Shu-Hang
Bai, Hua
Zhao, Jun
An, Tong-Tong
Duan, Jian-Chun
Wang, Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu Jiangyong
Yu Sifan
Wang Shuhang
Bai Hua
Zhao Jun
An Tongtong
Duan Jianchun
Wang Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Beau-Faller, M.
Prim, N.
Ruppert, A. M.
Nanni-Metellus, I.
Lacave, R.
Lacroix, L.
Escande, F.
Lizard, S.
Pretet, J. L.
Rouquette, I.
Cremoux, P.,
Solassol, Jérôme
Fraipont, F.,
Bieche, I.
Cayre, A.
Favre-Guillevin, E.
Tomasini, P.
Wislez, M.
Besse, B.
Legrain, M.
Voegeli, A. C.
Baudrin, L.
Morin, F.
Zalcman, G.
Quoix, E.
Blons, H.
Cadranel, J.

January 2014

International audienceBACKGROUND: There is scarce data available about epidermal growth factor recep...

Comparison of EGFR mutation between MPE-supernatant and matched MPTTs.

Dan Liu (108669)
Yachao Lu (528703)
Zhenli Hu (286020)
Ning Wu (132667)
Xiaomeng Nie (528704)
Yang Xia (104600)
Yiping Han (528705)
Qiang Li (8118)
Guanshan Zhu (528706)
Chong Bai (311317)

February 2014

MPTT: metastatic pleural tumor tissue; MPE: malignant pleural effusion;+<...

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma

Liu Dan
Lu Yachao
Hu Zhenli
Wu Ning
Nie Xiaomeng
Xia Yang
Han Yiping
Li Qiang
Zhu Guanshan
Bai Chong

February 2014

Though the possibility of using malignant pleural effusions (MPEs) as alternatives for metastatic pl...

Kappa value and Youden index of EGFR mutations in MPPT and that in MPE samples.

Dan Liu (108669)
Yachao Lu (528703)
Zhenli Hu (286020)
Ning Wu (132667)
Xiaomeng Nie (528704)
Yang Xia (104600)
Yiping Han (528705)
Qiang Li (8118)
Guanshan Zhu (528706)
Chong Bai (311317)

February 2014

MPTT: metastatic pleural tumor tissue; MPE: malignant pleural effusion;</p

Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.

Dan Liu
Yachao Lu
Zhenli Hu
Ning Wu
Xiaomeng Nie
Yang Xia
Yiping Han
Qiang Li
Guanshan Zhu
Chong Bai

BACKGROUND:Though the possibility of using malignant pleural effusions (MPEs) as alternatives for me...

Comparative analyses of IHC-based and molecular-based EGFR mutational status.

Guiyang Jiang (164288)
Chuifeng Fan (388070)
Xiupeng Zhang (388071)
Qianze Dong (164522)
Liang Wang (23021)
Yang Liu (4829)
Shundong Dai (190558)
Lianhe Yang (388072)
Yong Zhang (5893)
Juanhan Yu (164278)
Enhua Wang (93227)

March 2013

*:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.Oth...

Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma

吳尚俊
WU, SHANG-GIN

June 2011

Malignant pleural effusions (MPEs) are often observed in lung cancer, especially adenocarcinoma. Epi...

Frequent Epidermal Growth Factor Receptor Gene Mutations in Malignant Pleural Effusion of Lung Adenocarcinoma

吳尚俊
WU, SHANG-GIN

June 2011

Malignant pleural effusions (MPEs) are often observed in lung cancer, especially adenocarcinoma. Epi...

Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations

?????????

November 2011

Aims Deletion of exon 19 of the epidermal growth factor receptor (EGFR) and mutation of exon 21 are ...

A comparison of methods for EGFR mutation testing in non-small cell lung cancer.

Young, Elizabeth C.
Owens, Martina
Adebiyi, I
Bedenham, T
Butler, R
Callaway, J
Cranston, T
Crosby, C
Cree, I A
Dutton, L
Faulkes, C
Faulkner, C
Howard, E
Knight, J
Huang, Y
Lavender, L
Lazarou, L P
Liu, H
Mair, D
Milano, A
Sandell, S
Skinner, A
Wallace, A
Williams, M. V.
Spivey, V
Goodall, J
Frampton, J
Ellard, Sian

December 2013

EGFR mutation testing of tumor samples is routinely performed to predict sensitivity to treatment wi...

Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer

Lee, Victor H.F.
Tin, Vicky P.C.
Choy, Tim-shing
Lam, Ka-on
Choi, Cheuk-wai
Chung, Lap-ping
Tsang, Janice W.H.
Ho, Patty P.Y.
Leung, Dennis K.C.
Ma, Edmond S.K.
Liu, Jing
Shek, Tony W.H.
Kwong, Dora L.W.
Leung, To-wai
Wong, Maria P.

September 2013

Background:This study investigated whether there were differential survival outcomes to first-line t...

Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma.

Mezzapelle R
Rena O
Paganotti A
Allegrini S
Antona J
Molinari F
Frattini M
Monga G
MIGLIO, Umberto
ALABISO, Oscar
BOLDORINI, Renzo Luciano

January 2013

BACKGROUND: As epidermal growth factor receptor (EGFR) is involved in the pathogenesis of maligna...

Difference in types of EGFR mutations between tumors with mPAP and without mPAP element.

Mai Matsumura (3353702)
Koji Okudela (519804)
Yoko Kojima (3353705)
Shigeaki Umeda (519810)
Yoko Tateishi (519809)
Akimasa Sekine (610534)
Hiromasa Arai (3353699)
Tetsukan Woo (519806)
Michihiko Tajiri (519811)
Kenichi Ohashi (519813)

November 2016

Difference in types of EGFR mutations between tumors with mPAP and without mPAP element.</...

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu, Jiang-Yong
Yu, Si-Fan
Wang, Shu-Hang
Bai, Hua
Zhao, Jun
An, Tong-Tong
Duan, Jian-Chun
Wang, Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu Jiangyong
Yu Sifan
Wang Shuhang
Bai Hua
Zhao Jun
An Tongtong
Duan Jianchun
Wang Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Beau-Faller, M.
Prim, N.
Ruppert, A. M.
Nanni-Metellus, I.
Lacave, R.
Lacroix, L.
Escande, F.
Lizard, S.
Pretet, J. L.
Rouquette, I.
Cremoux, P.,
Solassol, Jérôme
Fraipont, F.,
Bieche, I.
Cayre, A.
Favre-Guillevin, E.
Tomasini, P.
Wislez, M.
Besse, B.
Legrain, M.
Voegeli, A. C.
Baudrin, L.
Morin, F.
Zalcman, G.
Quoix, E.
Blons, H.
Cadranel, J.

January 2014

International audienceBACKGROUND: There is scarce data available about epidermal growth factor recep...

Comparison of EGFR mutation between MPE-supernatant and matched MPTTs.

Dan Liu (108669)
Yachao Lu (528703)
Zhenli Hu (286020)
Ning Wu (132667)
Xiaomeng Nie (528704)
Yang Xia (104600)
Yiping Han (528705)
Qiang Li (8118)
Guanshan Zhu (528706)
Chong Bai (311317)

February 2014

MPTT: metastatic pleural tumor tissue; MPE: malignant pleural effusion;+<...

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma

Liu Dan
Lu Yachao
Hu Zhenli
Wu Ning
Nie Xiaomeng
Xia Yang
Han Yiping
Li Qiang
Zhu Guanshan
Bai Chong

February 2014

Though the possibility of using malignant pleural effusions (MPEs) as alternatives for metastatic pl...

Kappa value and Youden index of EGFR mutations in MPPT and that in MPE samples.

Dan Liu (108669)
Yachao Lu (528703)
Zhenli Hu (286020)
Ning Wu (132667)
Xiaomeng Nie (528704)
Yang Xia (104600)
Yiping Han (528705)
Qiang Li (8118)
Guanshan Zhu (528706)
Chong Bai (311317)

February 2014

MPTT: metastatic pleural tumor tissue; MPE: malignant pleural effusion;</p

Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.

Dan Liu
Yachao Lu
Zhenli Hu
Ning Wu
Xiaomeng Nie
Yang Xia
Yiping Han
Qiang Li
Guanshan Zhu
Chong Bai

BACKGROUND:Though the possibility of using malignant pleural effusions (MPEs) as alternatives for me...

Comparative analyses of IHC-based and molecular-based EGFR mutational status.

Guiyang Jiang (164288)
Chuifeng Fan (388070)
Xiupeng Zhang (388071)
Qianze Dong (164522)
Liang Wang (23021)
Yang Liu (4829)
Shundong Dai (190558)
Lianhe Yang (388072)
Yong Zhang (5893)
Juanhan Yu (164278)
Enhua Wang (93227)

March 2013

*:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.Oth...

Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma

吳尚俊
WU, SHANG-GIN

June 2011

Malignant pleural effusions (MPEs) are often observed in lung cancer, especially adenocarcinoma. Epi...

Frequent Epidermal Growth Factor Receptor Gene Mutations in Malignant Pleural Effusion of Lung Adenocarcinoma

吳尚俊
WU, SHANG-GIN

June 2011

Malignant pleural effusions (MPEs) are often observed in lung cancer, especially adenocarcinoma. Epi...

Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations

?????????

November 2011

Aims Deletion of exon 19 of the epidermal growth factor receptor (EGFR) and mutation of exon 21 are ...

A comparison of methods for EGFR mutation testing in non-small cell lung cancer.

Young, Elizabeth C.
Owens, Martina
Adebiyi, I
Bedenham, T
Butler, R
Callaway, J
Cranston, T
Crosby, C
Cree, I A
Dutton, L
Faulkes, C
Faulkner, C
Howard, E
Knight, J
Huang, Y
Lavender, L
Lazarou, L P
Liu, H
Mair, D
Milano, A
Sandell, S
Skinner, A
Wallace, A
Williams, M. V.
Spivey, V
Goodall, J
Frampton, J
Ellard, Sian

December 2013

EGFR mutation testing of tumor samples is routinely performed to predict sensitivity to treatment wi...

Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer

Lee, Victor H.F.
Tin, Vicky P.C.
Choy, Tim-shing
Lam, Ka-on
Choi, Cheuk-wai
Chung, Lap-ping
Tsang, Janice W.H.
Ho, Patty P.Y.
Leung, Dennis K.C.
Ma, Edmond S.K.
Liu, Jing
Shek, Tony W.H.
Kwong, Dora L.W.
Leung, To-wai
Wong, Maria P.

September 2013

Background:This study investigated whether there were differential survival outcomes to first-line t...

Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma.

Mezzapelle R
Rena O
Paganotti A
Allegrini S
Antona J
Molinari F
Frattini M
Monga G
MIGLIO, Umberto
ALABISO, Oscar
BOLDORINI, Renzo Luciano

January 2013

BACKGROUND: As epidermal growth factor receptor (EGFR) is involved in the pathogenesis of maligna...

Difference in types of EGFR mutations between tumors with mPAP and without mPAP element.

Mai Matsumura (3353702)
Koji Okudela (519804)
Yoko Kojima (3353705)
Shigeaki Umeda (519810)
Yoko Tateishi (519809)
Akimasa Sekine (610534)
Hiromasa Arai (3353699)
Tetsukan Woo (519806)
Michihiko Tajiri (519811)
Kenichi Ohashi (519813)

November 2016

Difference in types of EGFR mutations between tumors with mPAP and without mPAP element.</...

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu, Jiang-Yong
Yu, Si-Fan
Wang, Shu-Hang
Bai, Hua
Zhao, Jun
An, Tong-Tong
Duan, Jian-Chun
Wang, Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Yu Jiangyong
Yu Sifan
Wang Shuhang
Bai Hua
Zhao Jun
An Tongtong
Duan Jianchun
Wang Jie

January 2016

Background: Epidermal growth factor receptor (EGFR) mutations, including a known exon 19 deletion (1...

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Beau-Faller, M.
Prim, N.
Ruppert, A. M.
Nanni-Metellus, I.
Lacave, R.
Lacroix, L.
Escande, F.
Lizard, S.
Pretet, J. L.
Rouquette, I.
Cremoux, P.,
Solassol, Jérôme
Fraipont, F.,
Bieche, I.
Cayre, A.
Favre-Guillevin, E.
Tomasini, P.
Wislez, M.
Besse, B.
Legrain, M.
Voegeli, A. C.
Baudrin, L.
Morin, F.
Zalcman, G.
Quoix, E.
Blons, H.
Cadranel, J.

January 2014

International audienceBACKGROUND: There is scarce data available about epidermal growth factor recep...

Comparison of EGFR mutation between MPEs and matched MPTTs.

Abstract

Extracted data

Comparison of EGFR mutation between MPEs and matched MPTTs.

Abstract

Extracted data

Related items

Related items